Hyphens Pharma International Balance Sheet Health
Financial Health criteria checks 6/6
Hyphens Pharma International has a total shareholder equity of SGD65.9M and total debt of SGD3.2M, which brings its debt-to-equity ratio to 4.9%. Its total assets and total liabilities are SGD120.8M and SGD54.9M respectively. Hyphens Pharma International's EBIT is SGD11.1M making its interest coverage ratio -175.9. It has cash and short-term investments of SGD23.4M.
Key information
4.9%
Debt to equity ratio
S$3.23m
Debt
Interest coverage ratio | -175.9x |
Cash | S$23.37m |
Equity | S$65.86m |
Total liabilities | S$54.90m |
Total assets | S$120.77m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1J5's short term assets (SGD92.2M) exceed its short term liabilities (SGD49.2M).
Long Term Liabilities: 1J5's short term assets (SGD92.2M) exceed its long term liabilities (SGD5.7M).
Debt to Equity History and Analysis
Debt Level: 1J5 has more cash than its total debt.
Reducing Debt: 1J5's debt to equity ratio has reduced from 7.7% to 4.9% over the past 5 years.
Debt Coverage: 1J5's debt is well covered by operating cash flow (174.8%).
Interest Coverage: 1J5 earns more interest than it pays, so coverage of interest payments is not a concern.